Brain Oligomeric &bgr;-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice
暂无分享,去创建一个
Bradley T. Hyman | Mireia Coma | Alberto Serrano-Pozo | B. Hyman | T. Gómez-Isla | A. Serrano‐Pozo | T. Hashimoto | Bibiana DaRocha-Souto | Thomas C. Scotton | Tadafumi Hashimoto | Lidia Serenó | Marta Rodríguez | Belen Sánchez | Teresa Gómez-Isla | M. Coma | L. Serenó | B. DaRocha-Souto | T. C. Scotton | Marta Rodrı́guez | Belén Sánchez | Lidia Serenó
[1] B. Hyman,et al. APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.
[2] R. Malinow,et al. β-Amyloid Modulation of Synaptic Transmission and Plasticity , 2007, The Journal of Neuroscience.
[3] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[4] Shaomin Zhou,et al. Magnetic Properties of Ni-doped ZnO Nanocombs by CVD Approach , 2010, Nanoscale research letters.
[5] R. Malinow,et al. Beta-amyloid modulation of synaptic transmission and plasticity. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[6] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[7] R. J. McDonald,et al. The etiology of age-related dementia is more complicated than we think , 2010, Behavioural Brain Research.
[8] H Bratzke,et al. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. , 1998, Progress in brain research.
[9] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[10] Phillip B. Jones,et al. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. , 2007, The American journal of pathology.
[11] J. Trojanowski,et al. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. , 2006, The Journal of biological chemistry.
[12] J. Ávila,et al. Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation , 2005, Neuroscience.
[13] C. Olson,et al. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. , 1992, Cerebral cortex.
[14] Pierre J Magistretti,et al. Amyloid-β Aggregates Cause Alterations of Astrocytic Metabolic Phenotype: Impact on Neuronal Viability , 2010, The Journal of Neuroscience.
[15] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Malinow,et al. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.
[17] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[18] J. Lucas,et al. FTDP-17 Mutations in tau Transgenic Mice Provoke Lysosomal Abnormalities and Tau Filaments in Forebrain , 2001, Molecular and Cellular Neuroscience.
[19] C. Rowe,et al. 11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report. , 2010, Journal of Alzheimer's disease : JAD.
[20] T. Gómez-Isla,et al. A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo , 2009, Neurobiology of Disease.
[21] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[22] D. Selkoe,et al. Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.
[23] I Ferrer,et al. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. , 2005, Current Alzheimer research.
[24] D. Dickson,et al. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] W. Rosenblum. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. , 1997, Journal of neuropathology and experimental neurology.
[26] Bradley T. Hyman,et al. Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.
[27] B. Hyman,et al. In Vivo Multiphoton Imaging of a Transgenic Mouse Model of Alzheimer Disease Reveals Marked Thioflavine‐S‐Associated Alterations in Neurite Trajectories , 2003, Journal of neuropathology and experimental neurology.
[28] K. Pahan,et al. Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease , 2010, The Journal of Neuroscience.
[29] C. Masters,et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.
[30] Jaime Grutzendler,et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.
[31] L. S. Forsberg,et al. Mesorhizobium loti Produces nodPQ-Dependent Sulfated Cell Surface Polysaccharides , 2006, Journal of bacteriology.
[32] George A. Carlson,et al. The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[33] G. Collingridge,et al. Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodiesterase type 6 (PDE6) , 2003, Brain Research.
[34] C. Duyckaerts,et al. Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.
[35] Jill A. White,et al. Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation , 2005, Neurobiology of Disease.
[36] D. Selkoe,et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.
[37] S. Younkin,et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] O. Vitolo,et al. Amyloid β peptide adversely affects spine number and motility in hippocampal neurons , 2006, Molecular and Cellular Neuroscience.
[39] C. Duyckaerts,et al. Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model , 2004, Neurobiology of Disease.
[40] I. Kanazawa,et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC‐P/collagen type XXV , 2002, The EMBO journal.
[41] D. Dickson,et al. Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.
[42] J. D. McGaugh,et al. Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.
[43] B. Hyman,et al. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease , 2010, Neurobiology of Disease.
[44] Lars-Olof Wahlund,et al. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment , 2002, BMC neurology.
[45] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[46] C. Albanese,et al. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism , 1998 .
[47] L. Lue,et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.
[48] Kristina D. Micheva,et al. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.
[49] M. Staufenbiel,et al. Extracellular amyloid formation and associated pathology in neural grafts , 2003, Nature Neuroscience.
[50] W. Klein,et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[51] I. Ferrer,et al. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice , 2005, Neurobiology of Disease.
[52] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.
[53] Mark J West,et al. Hippocampal neurons in pre-clinical Alzheimer’s disease , 2004, Neurobiology of Aging.
[54] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[55] H. Gundersen,et al. Unbiased stereological estimation of the number of neurons in the human hippocampus , 1990, The Journal of comparative neurology.
[56] J. Hodges,et al. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.
[57] David W. Miller,et al. Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice , 2003, Neurobiology of Aging.
[58] M. Albert,et al. Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain , 2004, Neurology.